Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake

The company's step-down subsidiary Strides Pharma Global has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic products encompassing prescription and over-the-counter drugs across several therapeutic segments.

NEW DELHI: Strides Pharma Science on Wednesday said it has acquired 70% stake in Switzerland-based Fairmed Healthcare AG for CHF 2.2 million (over 15.50 crore).

The company's step-down subsidiary Strides Pharma Global has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic products encompassing prescription and over-the-counter drugs across several therapeutic segments, Strides Pharma said in a statement.

Read Also: Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

"Under the terms of the agreement, Strides Pharma Global Pte will hold 70% of the issued capital of Fairmed. Strides Pharma has infused CHF (Swiss franc) 2.2 million into the entity in lieu of the equity stake," it added.

The acquisition further strengthens Strides' footprint in continental Europe, it said.

Read Also: Strides Pharma gets zero USFDA observations for Alathur facility